Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder

Keith G Heinzerling
Keith G Heinzerling
Marisa Briones
Marisa Briones
April D Thames
April D Thames
Charles H Hinkin
Charles H Hinkin
Tianle Zhu
Tianle Zhu

Journal of Neuroimmune Pharmacology, pp. 238-248, 2020.

Cited by: 0|Views2
WOS

Abstract:

Methamphetamine (MA) triggers neuroinflammation and medications that counteract MA-induced neuroinflammation may reduce MA-induced neurodegeneration and improve neurocognition and treatment outcomes in MA use disorder. We performed a randomized, placebo-controlled trial to determine the safety and efficacy of ibudilast (IBUD), a phosphodi...More

Code:

Data:

Your rating :
0

 

Tags
Comments